Specifically, RBMS3 suppression was found to downregulate PD-L1 and enhance immune responses (Zhou et al., 2023), while metformin treatment increased RBMS3 expression and promoted ferroptosis in ovarian cancer cells (Zhao et al., 2025). The gene discussed is RBMS3; the disease is ovarian cancer.